Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of PET / MRI for the Assessment of Lymph Node Metastasis and Other Prognostic Factors in Patients With Rectal Cancer

NCT03846882 is registered in ClinicalTrials.gov with Region Västerbotten as lead sponsor.

NCT NCT03846882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03846882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of PET / MRI for the Assessment of Lymph Node Metastasis and Other Prognostic Factors in Patients With Rectal Cancer
Lead sponsor
Region Västerbotten
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2015
Completion date
December 31, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastases, rectal cancer